COVID-19 and emerging viral infections: The case for interferon lambda

With the first reports on coronavirus disease 2019 (COVID-19), which is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the scientific community working in the field of type III IFNs (IFN-λ) realized that this class of IFNs could play an important role in this and o...

Descripción completa

Detalles Bibliográficos
Autores principales: Prokunina-Olsson, Ludmila, Alphonse, Noémie, Dickenson, Ruth E., Durbin, Joan E., Glenn, Jeffrey S., Hartmann, Rune, Kotenko, Sergei V., Lazear, Helen M., O’Brien, Thomas R., Odendall, Charlotte, Onabajo, Olusegun O., Piontkivska, Helen, Santer, Deanna M., Reich, Nancy C., Wack, Andreas, Zanoni, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2020
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155807/
https://www.ncbi.nlm.nih.gov/pubmed/32289152
http://dx.doi.org/10.1084/jem.20200653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155807/
https://www.ncbi.nlm.nih.gov/pubmed/32289152
http://dx.doi.org/10.1084/jem.20200653

Ejemplares similares